Skip to main content
. 2020 Apr 19;35(7):1221–1230. doi: 10.1007/s00384-020-03582-2

Table 1.

Clinical and histopathological parameters of the patients and influence on anastomotic leakage

Patient characteristics Number of patients (n = 38) AL (n = 18) Non-AL (n = 20) p value
Tumor localization
  Colon 14 (36.8%) 3 (16.7%) 11 (55%) 0.014
  Rectum 24 (63.2%) 15 (83.3%) 9 (45%)
Median age 0.492
  ≤ 60 years 17 (44.7%) 7 (38.9%) 10 (50%)
  > 60 years 21 (55.3%) 11 (61.1%) 10 (50%)
Gender 0.043
  Male 28 (73.7%) 16 (88.9%) 12 (60%)
  Female 10 (26.3%) 2 (11.1%) 8 (40%)
BMI [kg/m2] 0.587
  < 25 16 (42.1%) 4 (22.2%) 6 (30%)
  ≥ 25 22 (57.9%) 14 (77.8%) 14 (70%)
Smoker 0.463
  Yes 27 (71%) 6 (33.3%) 9 (45%)
  No 11 (29%) 12 (66.7%) 11 (55%)
T category 0.253
  T1 0 (0%) 0 (0%) 0 (0%)
  T2 7 (18.4%) 4 (22.2%) 3 (15%)
  T3 25 (65.8%) 13 (72.2%) 12 (60%)
  T4 6 (15.8%) 1 (5.6%) 5 (25%)
N category
  N0 21 (55.2%) 9 (50%) 12 (60%) 0.582
  N1 11 (29%) 5 (27.8%) 6 (30%)
  N2 6 (15.8%) 4 (22.2%) 2 (10%)
M category
  M0 26 (68.4%) 10 (55.6%) 16 (80%)
  M1 12 (31.6%) 8 (44.4%) 4 (20%) 0.106
R 0.485
  R0 35 (92.1%) 16 (88.9%) 19 (95%)
  R1 3 (7.9%) 2 (11.1%) 1 (5%)
Grading 0.085
  G1 0 (0%) 0 (0%) 0 (0%)
  G2 19 (50%) 7 (38.9%) 12 (60%)
  G3 5 (13.2%) 4 (22.2%) 1 (5%)
n/a* 14 (36.8%) 7 (38.9%) 7 (35%)
Neoadjuvant therapy 0.804
  Yes 14 (36.8%) 7 (38.9%) 7 (35%)
  No 24 (63.2%) 11 (61.1%) 13 (65%)

n/a not available; *due to neoadjuvant radiochemotherapy